Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-27

FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for verapamil hydrochloride from Nivagen Pharmaceuticals, Inc., updating regulatory status for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Verapamil Hydrochloride (Verapamil hydrochloride)

Snippet

SUPPL AP for VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE)